Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Otto

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
European Journal of Internal Medicine|May 25, 2010
Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD)Tim Zimmermann, Maria Hoppe-Lotichius, Vuk Tripkovic, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 7, 2015
Graft rinse prior to reperfusion in liver transplantation: literature review and online survey within the Eurotransplant communityPhilipp Houben, Giulia Manzini, Michael Kremer, et al.
Hepatology (Baltimore, Md.)|February 21, 2013
Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cellsMartin Franz Sprinzl, Florian Reisinger, Andreas Puschnik, et al.
BMC Cancer|March 24, 2012
Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significanceMichael Heise, Anja Lautem, Johanna Knapstein, et al.
Journal of Clinical Gastroenterology|September 19, 2013
Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC RegistryArndt Weinmann, Sandra Koch, Ina M Niederle, et al.
Scandinavian Journal of Gastroenterology|April 5, 2012
Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liverMarcus A Wörns, Timon Bosslet, Anja Victor, et al.
International Journal of Oncology|February 27, 2013
Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinomaAnja Lautem, Michael Heise, Andreas Gräsel, et al.
United European Gastroenterology Journal|March 12, 2021
High pretreatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinomaCarolin Czauderna, Irene Schmidtmann, Sandra Koch, et al.
Gastroenterology|February 28, 2004
Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndromeSusanne Strand, Dennis Strand, Rudolf Seufert, et al.
United European Gastroenterology Journal|November 23, 2020
High pre-treatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinomaCarolin Czauderna, Irene Schmidtmann, Sandra Koch, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
European Journal of Internal Medicine|May 25, 2010
Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD)Tim Zimmermann, Maria Hoppe-Lotichius, Vuk Tripkovic, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 7, 2015
Graft rinse prior to reperfusion in liver transplantation: literature review and online survey within the Eurotransplant communityPhilipp Houben, Giulia Manzini, Michael Kremer, et al.
Hepatology (Baltimore, Md.)|February 21, 2013
Sorafenib perpetuates cellular anticancer effector functions by modulating the crosstalk between macrophages and natural killer cellsMartin Franz Sprinzl, Florian Reisinger, Andreas Puschnik, et al.
BMC Cancer|March 24, 2012
Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significanceMichael Heise, Anja Lautem, Johanna Knapstein, et al.
Journal of Clinical Gastroenterology|September 19, 2013
Trends in epidemiology, treatment, and survival of hepatocellular carcinoma patients between 1998 and 2009: an analysis of 1066 cases of a German HCC RegistryArndt Weinmann, Sandra Koch, Ina M Niederle, et al.
Scandinavian Journal of Gastroenterology|April 5, 2012
Prognostic factors and outcomes of patients with hepatocellular carcinoma in non-cirrhotic liverMarcus A Wörns, Timon Bosslet, Anja Victor, et al.
International Journal of Oncology|February 27, 2013
Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinomaAnja Lautem, Michael Heise, Andreas Gräsel, et al.
United European Gastroenterology Journal|March 12, 2021
High pretreatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinomaCarolin Czauderna, Irene Schmidtmann, Sandra Koch, et al.
Gastroenterology|February 28, 2004
Placenta-derived CD95 ligand causes liver damage in hemolysis, elevated liver enzymes, and low platelet count syndromeSusanne Strand, Dennis Strand, Rudolf Seufert, et al.
United European Gastroenterology Journal|November 23, 2020
High pre-treatment static and dynamic alpha-fetoprotein values predict reduced overall survival in hepatocellular carcinomaCarolin Czauderna, Irene Schmidtmann, Sandra Koch, et al.
Pageof 10